Clarity Pharmaceuticals (Clarity Pharmaceuticals) Book Value per Share : $0.27 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Clarity Pharmaceuticals Book Value per Share?

Clarity Pharmaceuticals's book value per share for the quarter that ended in Dec. 2023 was $0.27.

During the past 12 months, Clarity Pharmaceuticals's average Book Value Per Share Growth Rate was -35.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Clarity Pharmaceuticals's current price is $2.90. Its book value per share for the quarter that ended in Dec. 2023 was $0.27. Hence, today's PB Ratio of Clarity Pharmaceuticals is 16.29.

During the past 2 years, the highest P/B Ratio of Clarity Pharmaceuticals was 13.64. The lowest was 0.00. And the median was 0.00.

Clarity Pharmaceuticals Book Value per Share Historical Data

The historical data trend for Clarity Pharmaceuticals's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Book Value per Share Chart

Clarity Pharmaceuticals Annual Data

Trend

Jun22

Jun23

Book Value per Share

0.25

0.18

Clarity Pharmaceuticals Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Book Value per Share	Get a 7-Day Free Trial			0.40	0.25	0.42	0.18	0.27

Competitive Comparison of Clarity Pharmaceuticals's Book Value per Share

For the Biotechnology subindustry, Clarity Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clarity Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clarity Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Clarity Pharmaceuticals's PB Ratio falls into.

Clarity Pharmaceuticals Book Value per Share Calculation

Clarity Pharmaceuticals's Book Value Per Share for the fiscal year that ended in Jun. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(46.43	-	0.00)	/	261.47
	=	0.18

Clarity Pharmaceuticals's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(35.52	-	0.00)	/	134.01
	=	0.27

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Clarity Pharmaceuticals (OTCPK:CLRPF) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Clarity Pharmaceuticals Book Value per Share Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarity Pharmaceuticals (Clarity Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (OTCPK:CLRPF) » Definitions » Book Value per Share

Comparable Companies

Traded in Other Exchanges

CU6:Australia

Address

4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015

Website

https://www.claritypharmaceuticals.com

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.